Search results
Results from the WOW.Com Content Network
Vincristine, also known as leurocristine and marketed under the brand name Oncovin among others, is a chemotherapy medication used to treat a number of types of cancer. [5] This includes acute lymphocytic leukemia , acute myeloid leukemia , Hodgkin's disease , neuroblastoma , and small cell lung cancer among others. [ 5 ]
gastric cancer and cancer of the esophagogastric junction (Siewert classification III) EOX epirubicin, oxaliplatin, capecitabine: esophageal Cancer, gastric Cancer: EP etoposide, platinum agent: testicular cancer, germ cell tumors: EPOCH: etoposide, prednisone, vincristine (Oncovin), cyclophosphamide, and hydroxydaunorubicin: Non-Hodgkin ...
MOPP is a combination chemotherapy regimen used to treat Hodgkin lymphoma.The acronym is derived from the component drugs of the regimen: ustargen (also known as mechlorethamine, chlormethine, mustine, nitrogen mustard, or MSD)
Nutritional problems are also frequently seen in cancer patients at diagnosis and through chemotherapy treatment. Research suggests that in children and young people undergoing cancer treatment, parenteral nutrition may help with this leading to weight gain and increased calorie and protein intake, when compared to enteral nutrition.
Vinca alkaloids are now produced synthetically and used as drugs in cancer therapy and as immunosuppressive drugs. These compounds include vinblastine, vincristine, vindesine, and vinorelbine. Additional researched vinca alkaloids include vincaminol, vineridine, and vinburnine.
For patients receiving chemotherapy, cancer-related fatigue is a prevalent and crippling problem that drastically lowers quality of life and interferes with daily tasks. This weariness is similar to what healthy people go through, but it's more intense and enduring.
This combination of mechlorethamine, vincristine (Oncovin), procarbazine, and prednisone proved capable of curing almost 70% of patients with advanced-stage Hodgkin lymphoma. [12] [13] While MOPP was remarkably successful in curing advanced Hodgkin lymphoma, its toxicity remained significant.
Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively.